Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
PUT
Jacobs Solutions
J
$16.8B
| $3.28M | ﹤0.01% |
36,390
-31,675
| -47% | -$2.68M |
|
4302
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $3.28M | ﹤0.01% |
123,110
+35,090
| +40% | +$874K |
|
|
COHR
4303
DELISTED
Coherent Inc
COHR
| $3.28M | ﹤0.01% |
21,865
-40,343
| -65% | -$5.16M |
|
4304
PUT
Sprouts Farmers Market
SFM
$7.52B
| $3.28M | ﹤0.01% |
163,100
+54,300
| +50% | +$1.11M |
|
4305
CorVel
CRVL
$3.38B
| $3.28M | ﹤0.01% |
92,757
-42,549
| -31% | -$1.32M |
|
4306
CALL
Intellia Therapeutics
NTLA
$1.7B
| $3.27M | ﹤0.01% |
60,200
+30,100
| +100% | +$1.09M |
|
4307
PUT
Texas Roadhouse
TXRH
$13.4B
| $3.27M | ﹤0.01% |
41,900
-24,100
| -37% | -$1.79M |
|
4308
CALL
ProShares UltraPro Short S&P 500
SPXU
$401M
| $3.27M | ﹤0.01% |
5,525
-2,566
| -32% | -$1.84M |
|
4309
CALL
Evergy
EVRG
$19.4B
| $3.27M | ﹤0.01% |
58,900
+37,400
| +174% | +$2.05M |
|
|
TRQ
4310
CALL
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $3.27M | ﹤0.01% |
263,300
+245,530
| +1,382% | +$2.38M |
|
4311
Citizens Financial Group
CFG
$31.3B
| $3.27M | ﹤0.01% |
91,407
+45,608
| +100% | +$1.43M |
|
4312
First Bancorp
FBNC
$2.73B
| $3.27M | ﹤0.01% |
96,625
-15,141
| -14% | -$439K |
|
|
PDCO
4313
CALL
DELISTED
Patterson Companies, Inc.
PDCO
| $3.27M | ﹤0.01% |
110,300
-46,800
| -30% | -$1.33M |
|
|
AVAN.U
4314
DELISTED
Avanti Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
AVAN.U
| $3.27M | ﹤0.01% |
+301,489
| New | +$3.07M |
|
4315
State Street SPDR S&P 1500 Momentum Tilt ETF
MMTM
$165M
| $3.27M | ﹤0.01% |
20,143
+12,362
| +159% | +$1.91M |
|
|
HBI
4316
DELISTED
Hanesbrands
HBI
| $3.26M | ﹤0.01% |
223,897
-3,631,676
| -94% | -$54.8M |
|
4317
Hackett Group
HCKT
$259M
| $3.26M | ﹤0.01% |
226,726
+77,345
| +52% | +$1.07M |
|
4318
iShares MSCI India Small-Cap ETF
SMIN
$766M
| $3.26M | ﹤0.01% |
77,069
+35,045
| +83% | +$1.33M |
|
|
ZGNX
4319
CALL
DELISTED
Zogenix, Inc.
ZGNX
| $3.26M | ﹤0.01% |
163,000
+84,600
| +108% | +$1.73M |
|
4320
Nautilus Biotechnolgy
NAUT
$113M
| $3.25M | ﹤0.01% |
300,000
-5,677
| -2% | -$59.8K |
|
|
GBT
4321
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.25M | ﹤0.01% |
75,100
+11,700
| +18% | +$577K |
|
|
JAMF
4322
PUT
DELISTED
Jamf
JAMF
| $3.25M | ﹤0.01% |
108,700
+39,900
| +58% | +$1.32M |
|
4323
Lennar Class A
LEN
$20.8B
| $3.25M | ﹤0.01% |
+44,066
| New | +$3.3M |
|
4324
Innovator US Equity Ultra Buffer ETF March
UMAR
$195M
| $3.25M | ﹤0.01% |
117,141
+64,887
| +124% | +$1.78M |
|
|
HSKA
4325
DELISTED
Heska Corp
HSKA
| $3.25M | ﹤0.01% |
22,288
-5,335
| -19% | -$664K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.